ATE121618T1 - Gemischte lipid-bicarbonat-kolloidale partikel zur abgabe von arzneien und kalorien. - Google Patents

Gemischte lipid-bicarbonat-kolloidale partikel zur abgabe von arzneien und kalorien.

Info

Publication number
ATE121618T1
ATE121618T1 AT91917082T AT91917082T ATE121618T1 AT E121618 T1 ATE121618 T1 AT E121618T1 AT 91917082 T AT91917082 T AT 91917082T AT 91917082 T AT91917082 T AT 91917082T AT E121618 T1 ATE121618 T1 AT E121618T1
Authority
AT
Austria
Prior art keywords
calories
carbon atoms
colloidal particles
particles
bicarbonate
Prior art date
Application number
AT91917082T
Other languages
English (en)
Inventor
David W Yesair
Original Assignee
David W Yesair
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by David W Yesair filed Critical David W Yesair
Application granted granted Critical
Publication of ATE121618T1 publication Critical patent/ATE121618T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
    • A61K9/1075—Microemulsions or submicron emulsions; Preconcentrates or solids thereof; Micelles, e.g. made of phospholipids or block copolymers

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Dispersion Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biophysics (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
AT91917082T 1990-08-13 1991-08-12 Gemischte lipid-bicarbonat-kolloidale partikel zur abgabe von arzneien und kalorien. ATE121618T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US56724390A 1990-08-13 1990-08-13

Publications (1)

Publication Number Publication Date
ATE121618T1 true ATE121618T1 (de) 1995-05-15

Family

ID=24266341

Family Applications (1)

Application Number Title Priority Date Filing Date
AT91917082T ATE121618T1 (de) 1990-08-13 1991-08-12 Gemischte lipid-bicarbonat-kolloidale partikel zur abgabe von arzneien und kalorien.

Country Status (9)

Country Link
US (3) US5314921A (de)
EP (1) EP0543943B1 (de)
JP (1) JP3273785B2 (de)
AT (1) ATE121618T1 (de)
AU (1) AU666293B2 (de)
CA (1) CA2089003C (de)
DE (1) DE69109297T2 (de)
ES (1) ES2071332T3 (de)
WO (1) WO1992003121A1 (de)

Families Citing this family (39)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5891466A (en) * 1990-08-13 1999-04-06 Yesair; David W. Mixed Liped-Bicarbonate colloidal particles for delivering drugs or calories
DE69109297T2 (de) * 1990-08-13 1995-11-09 David W. Byfield Mass. Yesair Gemischte lipid-bicarbonat-kolloidale partikel zur abgabe von arzneien und kalorien.
GB9212511D0 (en) * 1992-06-12 1992-07-22 Cortecs Ltd Pharmaceutical compositions
US5514670A (en) * 1993-08-13 1996-05-07 Pharmos Corporation Submicron emulsions for delivery of peptides
US5744155A (en) * 1993-08-13 1998-04-28 Friedman; Doron Bioadhesive emulsion preparations for enhanced drug delivery
EP0750604B1 (de) * 1994-03-14 1997-12-29 Morten Sloth Weidner Methode zur solubilisierung organischer verbindungen in lipophilen systemen ,neue chemische komplexe solcher verbindungen und verschiedene anwendungen dieser komplexe
DE69614855T2 (de) * 1995-06-06 2002-03-28 Biomolecular Products Inc Gemischte lipid-bicarbonat kolloidale partikel zur abgabe von arzneistoffen oder kalorien
EP0969813B1 (de) * 1997-02-24 2004-09-29 S.L.A. Pharma AG Topische pharmazeutische zusammensetzung, enthaltend einen cholinergischen wirkstoff oder einen kalziumkanalblocker
US6086915A (en) * 1998-04-01 2000-07-11 Bioresponse L.L.C. Compositions and methods of adjusting steroid hormone metabolism through phytochemicals
US6524620B2 (en) 1998-07-20 2003-02-25 Andrx Pharmaceuticals, Inc. Diltiazem controlled release formulation and method of manufacture
EP1119360B1 (de) * 1998-09-08 2006-12-06 Biomolecular Products, Inc. Zusammenstellungen zur erhöhung der darmabsoption von fetten
US6172122B1 (en) 1998-12-17 2001-01-09 The Lubrizol Corporation Stable emulsions from gelled overbased substrates with surfactants and aqueous liquids
US6761903B2 (en) 1999-06-30 2004-07-13 Lipocine, Inc. Clear oil-containing pharmaceutical compositions containing a therapeutic agent
US6267985B1 (en) 1999-06-30 2001-07-31 Lipocine Inc. Clear oil-containing pharmaceutical compositions
US6294192B1 (en) 1999-02-26 2001-09-25 Lipocine, Inc. Triglyceride-free compositions and methods for improved delivery of hydrophobic therapeutic agents
US6248363B1 (en) * 1999-11-23 2001-06-19 Lipocine, Inc. Solid carriers for improved delivery of active ingredients in pharmaceutical compositions
US6383471B1 (en) 1999-04-06 2002-05-07 Lipocine, Inc. Compositions and methods for improved delivery of ionizable hydrophobic therapeutic agents
US20030236236A1 (en) * 1999-06-30 2003-12-25 Feng-Jing Chen Pharmaceutical compositions and dosage forms for administration of hydrophobic drugs
US6458383B2 (en) 1999-08-17 2002-10-01 Lipocine, Inc. Pharmaceutical dosage form for oral administration of hydrophilic drugs, particularly low molecular weight heparin
US6309663B1 (en) 1999-08-17 2001-10-30 Lipocine Inc. Triglyceride-free compositions and methods for enhanced absorption of hydrophilic therapeutic agents
US7732404B2 (en) * 1999-12-30 2010-06-08 Dexcel Ltd Pro-nanodispersion for the delivery of cyclosporin
US6861060B1 (en) 2000-04-21 2005-03-01 Elena Luriya Personal care formulations
DE60136648D1 (de) * 2000-12-05 2009-01-02 Los Angeles Childrens Hospital Pharmazeutische zusammensetzungen von fenretinid mit erhöhter bioverfügbarkeit und verfahren zu deren verwendung
CA2788500C (en) * 2001-10-11 2017-08-01 Biomolecular Products, Inc. Modifications of solid 3-sn-phosphoglycerides
US20050008686A1 (en) * 2003-01-15 2005-01-13 Mannino Raphael J. Cochleate preparations of fragile nutrients
WO2004069203A2 (en) * 2003-01-31 2004-08-19 Childrens Hospital Los Angeles Research Institute Oral compositions of fenretinide having increased bioavailability and methods of using the same
ES2297111T3 (es) * 2003-09-18 2008-05-01 Tecnimede-Sociedade Tecnico-Medicinal, S.A. Composicion farmaceutica de clorhidrato de diltiazem estable para aplicacion cutanea y proceso para su preparacion.
US20060003002A1 (en) * 2003-11-03 2006-01-05 Lipocine, Inc. Pharmaceutical compositions with synchronized solubilizer release
AU2007233155B2 (en) 2006-03-29 2012-04-26 Scitech Development Llc Liposomal nanoparticles and other formulations of fenretinide for use in therapy and drug delivery
EP2200613B1 (de) 2007-09-21 2018-09-05 The Johns Hopkins University Phenazin-derivate und ihre verwendungen
US8861813B2 (en) * 2008-03-13 2014-10-14 Mallinckrodt Llc Multi-function, foot-activated controller for imaging system
US11304960B2 (en) 2009-01-08 2022-04-19 Chandrashekar Giliyar Steroidal compositions
US20180153904A1 (en) 2010-11-30 2018-06-07 Lipocine Inc. High-strength testosterone undecanoate compositions
US9034858B2 (en) 2010-11-30 2015-05-19 Lipocine Inc. High-strength testosterone undecanoate compositions
US9358241B2 (en) 2010-11-30 2016-06-07 Lipocine Inc. High-strength testosterone undecanoate compositions
US20120148675A1 (en) 2010-12-10 2012-06-14 Basawaraj Chickmath Testosterone undecanoate compositions
WO2016033549A2 (en) 2014-08-28 2016-03-03 Lipocine Inc. (17-ß)-3-OXOANDROST-4-EN-17-YL TRIDECANOATE COMPOSITIONS AND METHODS OF THEIR PREPARATION AND USE
US9498485B2 (en) 2014-08-28 2016-11-22 Lipocine Inc. Bioavailable solid state (17-β)-hydroxy-4-androsten-3-one esters
EP3544614A4 (de) 2016-11-28 2020-08-05 Lipocine Inc. Orale testosteron-undecanoat-therapie

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA725596A (en) * 1960-08-26 1966-01-11 J. Wretlind Arvid Method of preparing intravenously injectable fat emulsions free from side reactions or complications
JPS5321393B2 (de) * 1974-10-19 1978-07-03
JPS53107408A (en) * 1977-02-28 1978-09-19 Yamanouchi Pharmaceut Co Ltd Micellar preparation for rectal infusion
NL7806048A (nl) * 1978-06-02 1979-12-04 Kali Chemie Pharma Gmbh Geneesmiddel met betere resorptie-eigenschappen en werkwijze voor de bereiding daarvan.
JPS6030652B2 (ja) * 1979-05-07 1985-07-17 株式会社ミドリ十字 静脈注射用脂肪乳剤
JPS5618914A (en) * 1979-07-25 1981-02-23 Eisai Co Ltd Ubidecarenone composition having good absorbability
FR2497668B1 (fr) * 1981-01-15 1986-03-21 Gattefosse Ets Sa Emulsions lipoproteiques injectables, leur procede de preparation et leurs applications en therapeutique
JPS57167926A (en) * 1981-04-08 1982-10-16 Mitsubishi Chem Ind Ltd External base for skin
WO1983000294A1 (en) * 1981-07-23 1983-02-03 Little Inc A Micellular drug delivery system
US4454113A (en) * 1982-09-21 1984-06-12 Scm Corporation Stabilization of oil and water emulsions using polyglycerol esters of fatty acids
US4874795A (en) * 1985-04-02 1989-10-17 Yesair David W Composition for delivery of orally administered drugs and other substances
IE59067B1 (en) * 1985-04-02 1993-12-15 Yesair David W Composition for delivery of orally administered drugs and other substances
US4849132A (en) * 1986-05-16 1989-07-18 Asahi Denka Kogyo Kabushiki Kaisha Surfactant composition having improved functions
DE69109297T2 (de) * 1990-08-13 1995-11-09 David W. Byfield Mass. Yesair Gemischte lipid-bicarbonat-kolloidale partikel zur abgabe von arzneien und kalorien.

Also Published As

Publication number Publication date
US5707873A (en) 1998-01-13
DE69109297D1 (de) 1995-06-01
CA2089003C (en) 2001-03-20
US5741822A (en) 1998-04-21
JP3273785B2 (ja) 2002-04-15
AU666293B2 (en) 1996-02-08
DE69109297T2 (de) 1995-11-09
JPH06503815A (ja) 1994-04-28
WO1992003121A1 (en) 1992-03-05
ES2071332T3 (es) 1995-06-16
US5314921A (en) 1994-05-24
CA2089003A1 (en) 1992-02-14
AU8646291A (en) 1992-03-17
EP0543943A1 (de) 1993-06-02
EP0543943B1 (de) 1995-04-26

Similar Documents

Publication Publication Date Title
ATE121618T1 (de) Gemischte lipid-bicarbonat-kolloidale partikel zur abgabe von arzneien und kalorien.
HK1033263A1 (en) Pharmaceutical compositions capable of being gelled
ATE183926T1 (de) Hautpermeabilitaetserhöher bestehend aus monoglycerid/laktat estern
MY110734A (en) Improvements in or relating to dioic acids.
KR970704433A (ko) 의약 조성물로서의 DHA의 용도(Use of DHA as a pharmaceutical composition)
AU2671292A (en) Use of an emulsion to prepare an intravenously administered medicament for treating skin diseases
DE2964963D1 (en) Medical food based on liver powder and process for its preparation
SI9520139B (sl) Halkoni in njihovi estri z antiproliferativno učinkovitostjo na tumorje maternice, jajčnikov in dojk
EP0137543A3 (en) Pharmaceutical composition for the therapy of peripheral arteriopathies
GB2004741A (en) Cosmetic and pharmaceutical compositions for the skin
AU554413B2 (en) Linoleic acid and essential fatty acid compositions as
AU563273B2 (en) Composition containing an essential fatty acid and niacin and/or a bile salt binder
DE69614855T2 (de) Gemischte lipid-bicarbonat kolloidale partikel zur abgabe von arzneistoffen oder kalorien
NZ332497A (en) Pharmaceutical composition having a carrier system containing a combination of an alkylene glycol and unsaturated fatty acid alcohol as the solvent and a stiffening agent
KR890701098A (ko) 히드로퀴논 및 코지산을 함유하는 제약 또는 화장제 조성물
EP0238198A3 (de) Verfahren zur Abänderung der Lipid-Struktur-Funktion und von Zellmembranen und pharmazeutische Zusammensetzungen zur Verwendung dabei
GR3034803T3 (en) Low-dose steroid tablets containing gallic acid esters as antioxidant agent, process for the manufacture of said tablets, and uses of said tablets
AU7338587A (en) Pharmaceutical compositions of furosemide, piretanide or lemidosul in a fatty acid alkanolamide base
ES2172172T3 (es) Composiciones farmaceuticas solidas para la administracion por via oral que permiten la liberacion modulada de nicorandil y su procedimiento de preparacion.
GB8804188D0 (en) Pharmaceutical compositions
YU48388B (sh) Postupak za dobijanje farmaceutske masti koja ne iritira kožu
DK576086A (da) Blanding til afgivelse af oralt indgivelige stoffer
BG96407A (en) Medicaments for local treatment of wounds and inflammatory foci

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
REN Ceased due to non-payment of the annual fee